New York, NY -- (SBWIRE) -- 01/10/2014 -- PennyStockChronicle covers the breadth of the markets, from NASDAQ, NYSE, AMEX, ETF, Penny Stocks, Emerging Markets, activities at the Fed and more. PennyStockChronicle brings you the most vibrant coverage of following stocks: Mechel OAO (ADR) (NYSE:MTL), WPCS International Incorporated (NASDAQ:WPCS), Extreme Networks, Inc (NASDAQ:EXTR), DURECT Corporation (NASDAQ:DRRX)
Mechel OAO (ADR) (NYSE:MTL) showed a volume of 1.55 million shares by the end of last trade whereas the average volume of the stock remained 1.42 million shares. The stock opened the session at $2.27 but then moved to $2.28. At that price, the stock showed a negative performance of -0.44%. Mechel OAO is a Russia-based integrated mining and steel company. The Company focuses on the production of mining products, such as coal, iron ore, nickel, and steel products. Its operations are divided into two segments: Mining and Steel. The Mining segment focuses on the production and sales of coking coal concentrate, iron ore concentrate and coke with assets in the Russian Federation and the United States.
Will MTL Get Buyers Even After The Recent Rally? Find Out Here
WPCS International Incorporated (NASDAQ:WPCS) opened the session at $2.02 and closed the session at $2.05. The stock showed a positive performance of 1.49% in previous trading session. WPCS International Incorporated (WPCS) is a provider of design-build engineering services for communications infrastructure with five operations centers on three continents. As of April 30, 2013, WPCS operated in three business segments: wireless communication; specialty construction; and electrical power.
For How Long WPCS will fight for Profitability? Read This Trend Analysis report
Extreme Networks, Inc (NASDAQ:EXTR) opened the session at $7.20 and closed the session at $7.33. The stock showed a positive performance of 2.23% in previous trading session. The beta of the stock remained 1.67. Extreme Networks, Inc. together with its subsidiaries, is a provider of network infrastructure equipment and services for enterprises, data centers, and service providers. The Company’s customers include businesses, hospitals, schools, hotels, telecommunications companies and government agencies globally.
Why Should Investors Buy EXTR After The Recent Gain? Just Go Here and Find Out
DURECT Corporation (NASDAQ:DRRX) the stock advanced 5.95% and finished the session at $1.96. Traded with volume of 1.52 million shares in the prior session and the average volume of the stock remained 721,812.00 shares. The beta of the stock remained 1.55. Durect Corporation is a specialty pharmaceutical company focused on the development of pharmaceutical products based on its drug delivery technology platforms. The Company’s product pipeline, as of December 31, 2012, consisted of eight investigational drug candidates in clinical development, with one program the subject of a New Drug Application (NDA) with the United States Food and Drug Administration (FDA),
Will DRRX Continue To Move Higher? Find Out Here
Penny Stock Chronicle is comprised of a team of vetted penny stock traders who’ve been trading since 2008 & have developed the skills needed to trade for consistent profits.
PLEASE NOTE WELL: The employees of PennyStockChronicle.com are not registered as Investment Advisors in any jurisdiction whatsoever. Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. Investing in “penny stocks” is highly speculative.
Verify all claims and do your own due diligence on all securities. PennyStockChronicle.com profiles are not a solicitation or recommendation to buy, sell or hold securities. PennyStockChronicle.com is not offering securities for sale. Neither PennyStockChronicle.com nor its owners, operators, affiliates or anyone disseminating information on its behalf is registered as an Investment Advisor under any federal or state law and none of the information provided by PennyStockChronicle.com, its owners, operators, affiliates or anyone disseminating information on its behalf should be construed as investment advice or investment recommendations. PennyStockChronicle.com does not recommend that the securities profiled should be purchased, sold or held.
Read Full Disclaimer at: http://pennystockchronicle.com/disclaimer
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)